Simplex Trading
BDTX icon

Simplex Trading’s Black Diamond Therapeutics BDTX Stock Holding History

Simplex Trading’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2K Buy
+6,200
New +$14.7K ﹤0.01% 7105
2025
Q4 		– Sell
-24,000
Closed -$90K – 8557
2025
Q3 		$90K Buy
24,000
+7,900
+49% +$23.1K ﹤0.01% 5865
2025
Q2 		$39K Sell
16,100
-29,900
-65% -$57.6K ﹤0.01% 6161
2025
Q1 		$71K Buy
46,000
+31,400
+215% +$65.8K ﹤0.01% 5426
2024
Q4 		$31K Sell
14,600
-231,700
-94% -$664K ﹤0.01% 6312
2024
Q3 		$1.07M Buy
246,300
+244,700
+15,294% +$1.33M ﹤0.01% 2864
2024
Q2 		$7K Sell
1,600
-200
-11% -$1.07K ﹤0.01% 7645
2024
Q1 		$9K Sell
1,800
-10,500
-85% -$42.3K ﹤0.01% 7650
2023
Q4 		$34K Sell
12,300
-93,100
-88% -$218K ﹤0.01% 6447
2023
Q3 		$302K Buy
105,400
+21,700
+26% +$79.9K ﹤0.01% 3932
2023
Q2 		$422K Buy
83,700
+83,100
+13,850% +$170K ﹤0.01% 3481
2023
Q1 		$1K Sell
600
-12,300
-95% -$28.3K ﹤0.01% 8645
2022
Q4 		$23K Sell
12,900
-250,200
-95% -$451K ﹤0.01% 6717
2022
Q3 		$444K Buy
263,100
+33,300
+14% +$103K ﹤0.01% 3598
2022
Q2 		$565K Buy
+229,800
New +$534K ﹤0.01% 3291
2022
Q1 		– Sell
-900
Closed -$4K – 10380
2021
Q4 		$4K Sell
900
-6,100
-87% -$42.6K ﹤0.01% 9639
2021
Q3 		$86K Hold
7,000
– – ﹤0.01% 6821
2021
Q2 		$85K Buy
7,000
+6,999
+699,900% +$138K ﹤0.01% 6959
2021
Q1 		$2K Buy
+1
New +$27 ﹤0.01% 8420

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Simplex Trading's BDTX Position: Q3 2025 in Review

Simplex Trading sold out of Black Diamond Therapeutics (BDTX) in Q3 2025, closing a stake of 2,186 shares — an estimated $6.39K sold.

Simplex Trading first reported a position in BDTX in Q1 2021 and held it in 12 quarters. The position peaked at $98K in Q2 2024. 91 funds tracked by Wall St. Rank hold BDTX as of Q3 2025.

  • Simplex Trading reported no remaining Black Diamond Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,186 Black Diamond Therapeutics shares in Q3 2025, an estimated $6.39K.
  • Simplex Trading first reported a position in Black Diamond Therapeutics in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Black Diamond Therapeutics position peaked at $98K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.